中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2015年
19期
27-29
,共3页
肠易激综合征%中医药疗法%参苓白术散
腸易激綜閤徵%中醫藥療法%參苓白術散
장역격종합정%중의약요법%삼령백술산
Irritable Bowel Syndrome%TCM therapy%Shenling Baizhu San
目的:观察参苓白术散治疗腹泻型肠易激综合征(IBS)的临床疗效,探讨腹泻型IBS的中医病机.方法:选取腹泻型肠易激综合征患者,共60例,随机分为治疗组和对照组,治疗组予参苓白术散加减治疗,对照组予匹维溴胺50mg,3次/d,疗程均为2周,比较两组的临床疗效.结果:治疗组的疗效显著优于对照组(P<0.01).结论:参苓白术散治疗腹泻型肠易激综合征较匹维溴胺有一定优势,尤其在改善患者的腹痛或腹部不适方面,疗效更好.本研究中,治疗组以健脾化湿为法,取得良好的临床疗效,进一步证明了脾虚湿盛是腹泻型肠易激综合征的基本的中医病机.
目的:觀察參苓白術散治療腹瀉型腸易激綜閤徵(IBS)的臨床療效,探討腹瀉型IBS的中醫病機.方法:選取腹瀉型腸易激綜閤徵患者,共60例,隨機分為治療組和對照組,治療組予參苓白術散加減治療,對照組予匹維溴胺50mg,3次/d,療程均為2週,比較兩組的臨床療效.結果:治療組的療效顯著優于對照組(P<0.01).結論:參苓白術散治療腹瀉型腸易激綜閤徵較匹維溴胺有一定優勢,尤其在改善患者的腹痛或腹部不適方麵,療效更好.本研究中,治療組以健脾化濕為法,取得良好的臨床療效,進一步證明瞭脾虛濕盛是腹瀉型腸易激綜閤徵的基本的中醫病機.
목적:관찰삼령백술산치료복사형장역격종합정(IBS)적림상료효,탐토복사형IBS적중의병궤.방법:선취복사형장역격종합정환자,공60례,수궤분위치료조화대조조,치료조여삼령백술산가감치료,대조조여필유추알50mg,3차/d,료정균위2주,비교량조적림상료효.결과:치료조적료효현저우우대조조(P<0.01).결론:삼령백술산치료복사형장역격종합정교필유추알유일정우세,우기재개선환자적복통혹복부불괄방면,료효경호.본연구중,치료조이건비화습위법,취득량호적림상료효,진일보증명료비허습성시복사형장역격종합정적기본적중의병궤.
Objective: To observe and evaluate clinical efficacy of Shenling Baizhu San in treating the diarrhea type of IBS (IBS-D). Methods: A total 60 cases of IBS-D, randomly divided into the treatment group and the control group, two weeks course of treatment, clinical effect was compared. Results: Clinical effects in the treatment group was better than that in the control group. Conclusion: Curative effect in the treatment group surpassed the control group, showed that SLBZS was better than Pinaveriun Bromide tablets in treating IBS-D. Better curative effect further proves that spleen deficiency and moisture was the essential TCM pathogenesis of IBS.
